Biogen earnings, Revenue beat in Q4

  • Investing.com
  • Stock Market News
Biogen earnings, Revenue beat in Q4

Investing.com - Biogen (NASDAQ: BIIB ) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Biogen announced earnings per share of $3.39 on revenue of $2.73B. Analysts polled by Investing.com anticipated EPS of $3.35 on revenue of $2.62B.

Biogen shares are down 6% from the beginning of the year and are trading at $224.96 , down-from-52-week-high.They are under-performing the S&P 500 which is down 3.71% year to date.

Biogen follows other major Healthcare sector earnings this month

Biogen's report follows an earnings beat by J&J on Tuesday, January 25, 2022, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.

UnitedHealth had beat expectations on Wednesday, January 19, 2022 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles